Table 1.
Variable | |
---|---|
Number of patients | 16,162 |
Age, years, Mean ± SD | 77 ± 9 |
Male, n (%) | 8,596 (53.2) |
Baseline NIHSS score, (median [IQR])* | 5 (2–12) |
CHA2DS2-VASc score, (median [IQR]) | 4 (3–5) |
Prior medical history | |
Ischemic stroke/TIA, n (%) | 4,544 (28.1) |
Hypertension, n (%) | 13,320 (82.4) |
Diabetes, n (%) | 3,118 (19.3) |
Dyslipidemia, n (%) | 5,796 (35.9) |
Coronary heart disease, n (%) | 3,190 (19.7) |
Smoking, n (%) | 3,965 (24.5) |
Reperfusion therapy, n (%) | 2,919 (18.1) |
Number of eligible patients for antithrombotic agents at discharge | 14,838 |
Antiplatelets only, n (%) | 5,895 (39.7) |
Anticoagulants only, n (%) | 6,061 (40.8) |
Antiplatelets and Anticoagulants, n (%) | 274 (1.8) |
No-antithrombotic agent due to clear documentation of refusal or transfer to another hospital, n (%) | 904 (6.1) |
No-antithrombotic agent due to unknown reasons, n (%) | 1,704 (11.5) |
Types of anticoagulants | 6,335 |
Warfarin, n (%) | 2,916 (46.0) |
Direct oral anticoagulants, n (%) | 3,419 (54.0) |
IQR indicates interquartile range; SD, standard deviation; NIHSS, National Institutes of Health Stroke Scale; TIA, Transient ischemic attack.
NIHSS was available for 13,766 patients.